SEARCH RESULTS FOR: 得克萨斯A(13611 results)

Export results
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

HYDROPHILIC COATED NEPHROURETERAL STENT CATHETER, 8F, 26 cm Pig-to-Pig
URESIL, LLC
NSL2T-0826H
In Commercial Distribution

  • 10817640020186 ()
  • 00817640020189 ()
  • 20817640020183 ()
  • H862NSL2T0826H0 ()

  • Catheter Gauge: 8 French
  • Length: 26 Centimeter
NSL2T-0826H

  • Nephrostomy catheter
HYDROPHILIC COATED NEPHROURETERAL STENT CATHETER, 8F, 24 cm Pig-to-Pig
URESIL, LLC
NSL2T-0824H
In Commercial Distribution

  • 10817640020179 ()
  • 00817640020172 ()
  • 20817640020176 ()
  • H862NSL2T0824H0 ()

  • Catheter Gauge: 8 French
  • Length: 24 Centimeter
NSL2T-0824H

  • Nephrostomy catheter
HYDROPHILIC COATED NEPHROURETERAL STENT CATHETER, 8F, 22 cm Pig-to-Pig
URESIL, LLC
NSL2T-0822H
In Commercial Distribution

  • 10817640020162 ()
  • 00817640020165 ()
  • 20817640020169 ()
  • H862NSL2T0822H0 ()

  • Catheter Gauge: 8 French
  • Length: 22 Centimeter
NSL2T-0822H

  • Nephrostomy catheter
Cadexomer Iodine Pad
SMITH & NEPHEW MEDICAL LIMITED
6602134010
In Commercial Distribution

  • 00040565122533 ()
  • 00040565122526 ()
  • 30040565122534 ()
6602134010

  • Exudate-absorbent dressing, hydrophilic-gel, antimicrobial
Cadexomer Iodine Pad
SMITH & NEPHEW MEDICAL LIMITED
6602133005
In Commercial Distribution

  • 00040565122519 ()
  • 00040565122502 ()
  • 30040565122510 ()
6602133005

  • Exudate-absorbent dressing, hydrophilic-gel, antimicrobial
Cadexomer Iodine Gel
SMITH & NEPHEW MEDICAL LIMITED
6602125040
In Commercial Distribution

  • 30040565122497 ()
  • 00040565122496 ()
6602125040

  • Exudate-absorbent dressing, hydrophilic-gel, antimicrobial
The Lacriflow CL is indicated in treatments of epiphora in patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-CL090A
In Commercial Distribution

  • 14540778171395 ()
  • 04540778171398 ()

  • Length: 90 Millimeter


  • Lacrimal tube
The Lacriflow CL is indicated in treatments of epiphora in patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-CL105A
In Commercial Distribution

  • 04540778171381 ()
  • 14540778171388 ()

  • Length: 105 Millimeter


  • Lacrimal tube
The LACRIFLOW is indicated in treatments of epiphora in-patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-R090A
In Commercial Distribution

  • 04540778140875 ()
  • 14540778140872 ()

  • Length: 90 Millimeter


  • Lacrimal tube
The LACRIFLOW is indicated in treatments of epiphora in-patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-R105A
In Commercial Distribution

  • 04540778140868 ()
  • 14540778140865 ()

  • Length: 105 Millimeter


  • Lacrimal tube
< 1 ... 845 846 847 848 849 ... 1000 >